HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haruyasu Sakuranaka Selected Research

Haruyasu Sakuranaka Research Topics

Disease

2Neoplasms (Cancer)
11/2014 - 02/2012
1Lung Injury
01/2022
1Fever (Fevers)
01/2022
1Foreign Bodies (Foreign Body)
01/2022
1Cough
01/2022
1Adenocarcinoma
01/2016
1Adenocarcinoma of Lung
01/2016
1Meningeal Carcinomatosis
01/2016
1Hepatocellular Carcinoma (Hepatoma)
11/2014
1Lung Neoplasms (Lung Cancer)
11/2014
1Lymphangitis
11/2013
1Stomach Neoplasms (Stomach Cancer)
11/2013
1Interdigitating Dendritic Cell Sarcoma
02/2012
1Pathologic Complete Response
02/2012

Drug/Important Bio-Agent (IBA)

1Methotrexate (Mexate)FDA LinkGeneric
01/2022
1ErbB Receptors (EGF Receptor)IBA
01/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1AfatinibIBA
01/2016
1GadoliniumIBA
11/2014
1Pemetrexed (MTA)FDA Link
11/2014
1Cisplatin (Platino)FDA LinkGeneric
11/2014
1Pentetic Acid (DTPA)FDA LinkGeneric
11/2014
1PlatinumIBA
11/2014
1Carboplatin (JM8)FDA LinkGeneric
11/2014
1Docetaxel (Taxotere)FDA Link
11/2013
1S 1 (combination)IBA
11/2013
1Peroxidase (Myeloperoxidase)IBA
02/2012
1chloroacetic acid (chloroacetate)IBA
02/2012
1NaphtholsIBA
02/2012
1EsterasesIBA
02/2012

Therapy/Procedure

2Combination Drug Therapy (Combination Chemotherapy)
11/2014 - 11/2013
2Drug Therapy (Chemotherapy)
11/2013 - 02/2012
1Stem Cell Transplantation
02/2012
1Therapeutics
02/2012